Keating Investment Counselors Inc Astrazeneca PLC Transaction History

Keating Investment Counselors Inc

$230 Million
Q2 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	SELL	$61.03 - $69.57 $16,783 - $19,131	-275 Reduced 3.57%	7,418 $502,000
Q4 2023 Feb 07, 2024	SELL	$61.89 - $69.28 $4,641 - $5,196	-75 Reduced 0.97%	7,693 $518,000
Q3 2023 Oct 25, 2023	BUY	$64.85 - $71.7 $503,754 - $556,965	7,768 New	7,768 $526,000
Q2 2021 Jul 29, 2021	SELL	$48.42 - $60.18 $217,357 - $270,148	-4,489 Closed	0 $0
Q1 2021 Apr 26, 2021	SELL	$47.16 - $54.44 $33,012 - $38,108	-700 Reduced 13.49%	4,489 $223,000
Q2 2020 Jul 22, 2020	BUY	$43.1 - $55.31 $13,102 - $16,814	304 Added 6.22%	5,189 $274,000
Q1 2020 Apr 29, 2020	SELL	$37.79 - $51.33 $119,038 - $161,689	-3,150 Reduced 39.2%	4,885 $218,000
Q4 2019 Jan 28, 2020	SELL	$42.46 - $50.46 $4,246 - $5,046	-100 Reduced 1.23%	8,035 $401,000
Q3 2019 Oct 28, 2019	SELL	$40.12 - $45.47 $68,204 - $77,299	-1,700 Reduced 17.29%	8,135 $363,000
Q2 2019 Aug 01, 2019	SELL	$37.28 - $41.68 $517,819 - $578,935	-13,890 Reduced 58.55%	9,835 $406,000
Q1 2019 Apr 22, 2019	SELL	$35.49 - $43.02 $2 Million - $2.43 Million	-56,385 Reduced 70.38%	23,725 $959,000
Q4 2018 Feb 12, 2019	SELL	$36.86 - $41.49 $1.04 Million - $1.17 Million	-28,125 Reduced 25.99%	80,110 $3.04 Million
Q3 2018 Oct 30, 2018	SELL	$34.76 - $39.72 $4.17 Million - $4.76 Million	-119,850 Reduced 52.55%	108,235 $4.28 Million
Q2 2018 Aug 01, 2018	SELL	$34.55 - $37.05 $710,866 - $762,303	-20,575 Reduced 8.27%	228,085 $8.01 Million
Q1 2018 May 11, 2018	SELL	$32.97 - $36.63 $313,215 - $347,985	-9,500 Reduced 3.68%	248,660 $8.7 Million
Q4 2017 Feb 14, 2018	SELL	$32.09 - $34.78 $6,418 - $6,956	-200 Reduced 0.08%	258,160 $8.96 Million
Q3 2017 Nov 09, 2017	SELL	$28.96 - $34.0 $92,672 - $108,800	-3,200 Reduced 1.22%	258,360 $8.75 Million
Q2 2017 Aug 10, 2017	BUY	N/A	261,560	261,560 $8.92 Million

Others Institutions Holding AZN

# of Institutions

1,331

Shares Held

490M

Call Options Held

4.99M

Put Options Held

3.19M

Price T Rowe Associates Inc Baltimore, MD

64.9M
Shares

$5.39 Billion
0.61% of portfolio
Primecap Management CO Pasadena, CA

42.6M
Shares

$3.54 Billion
2.44% of portfolio
Wellington Management Group LLP Boston, MA

40.6M
Shares

$3.37 Billion
0.58% of portfolio
Capital International Investors Los Angeles, CA

36.7M
Shares

$3.05 Billion
0.6% of portfolio
Franklin Resources Inc San Mateo, CA

17.6M
Shares

$1.46 Billion
0.44% of portfolio

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $257B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Keating Investment Counselors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Keating Investment Counselors Inc with notifications on news.

Account